je.st
news
M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down
2015-12-14 20:08:05| Biotech - Topix.net
Michael Yee of RBC Capital Markets commented in a note that M&A activity within small- and mid-cap healthcare companies "doesn't seem to be slowing down much." Yee added that "good" late-stage and de-risked drugs should command a high value, regardless of any political uncertainty.
Tags: small
slowing
midcap
biotechs
Category:Biotechnology and Pharmaceuticals